ERBB2 and diabetes mellitus: There was no significant difference between the MSS and MSI groups in terms of age, sex, BMI, diabetes mellitus, history of CAD, family tumor history, smoking/alcohol consumption status, tumor size, tumor stage, the degree of differentiation, and HER2 gene amplification.